Gut microorganisms, mammalian metabolism and personalized health care

Nature Reviews Microbiology

Volumn 3, Issue 5, 2005, Pages 431-438

  Nicholson, Jeremy K ^a   Holmes, Elaine ^a   Wilson, Ian D ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALIN; XENOBIOTIC AGENT;

ARTICLE; DRUG DISPOSITION; HEALTH CARE; HOST; HUMAN; INTESTINE FLORA; MAMMAL; METABOLISM; METABOLOMICS; MICROBIAL ACTIVITY; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL INFECTIONS; GASTROINTESTINAL TRACT; HUMANS; MAMMALS; SELF CARE;

EID: 17844404232     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1152     Document Type: Article

References (87)

1. Urbanczyk-Wochniak, E. et al. Parallel analysis of transcript and metabolic profiles: a new approach in systems biology. EMBO Rep. 4, 989-993 (2003).
2. Nicholson, J. K., Holmes, E., Lindon, J. C. & Wilson, I. D. The challenges of modelling mammalian biocomplexity. Nature Biotechnol. 22, 1268-1274 (2004).
3. Hood, L. & Galas, D. The digital code of DNA. Nature 421, 444-448 (2003).
4. Smith L. L. Key challenges for toxicologists in the 21st Century. Trend. Pharm. Sci. 22, 281-285 (2001).
5. Ungelman-Sundberg, M. Pharmacogenetics of cytochrome P450 & its application in drug therapy: the past, present and future. Trend. Pharm. Sci. 25, 193-200 (2004).
6. Nebert, D. W., Jorge-Nebert, L. & Vesell, E. S. Pharmacogenomics and 'individualized drug therapy': high expectations and disappointing achievements. Am. J. Pharmacogenomics 3, 361-370 (2003).
7. Nicholson, J. K., Connelly, J., Lindon, J. C. & Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Disc. 1, 153-161 (2002).
8. Lindon, J. C., Nicholson, J. K., Holmes, E. & Everett, J. R. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts. Magn. Reson. 12, 289-320 (2000).
9. Farthing M. J. G. Bugs and the gut: an unstable marriage. Best Pract. Res. Clin. Gastroent. 18, 233-239 (2004).
10. Guarner, F. & Malagelada, J. R. Gut flora in health and disease. Lancet 361, 512-519 (2003).
11. Nicholls, A. W., Mortishire-Smith, R. J. & Nicholson, J. K. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, 1395-1404 (2003).
12. Bull, T. J. et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's Disease. J. Clin. Microbiol. 41, 2915-2923 (2003).
13. Lhoste, E. F. et al. The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem. Toxicol. 41, 695-702 (2003).
14. Xu, J. & Gordon, J. I. Honor thy symbionts. Proc. Natl Acad. Sci. USA 100, 10452-10459 (2003).
15. Todar, K. The bacterial flora of humans. Todar's online textbook of bacteriology [online], http://textbookofbacteriology.net (2004).
16. Suau, A. et al. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst. Appl. Microbiol. 24, 139-145 (2001).
17. Suau, A. et al. Direct rDNA community analysis reveals a myriad of novel bacterial lineages within the human gut. Appl. Environ. Microbiol. 65, 4799-4807 (1999).
18. Upreti, R. K., Shrivastava, R. & Chaturvedi, U. C. Gut microflora and toxic metals: chromium as a model. Indian J. Med. Res. 119, 49-59 (2004).
19. Acheson D. W. K. Mucosal immune responses. Best Pract. Res. Clin. Gastroent. 18, 387-404 (2004).
20. Hooper, L. V., Bry, L., Falk, P. G. & Gordon, J. I. Host-microbial symbiosis in the mammalian intestine: exploring an intestinal ecosystem. Bioessays 20, 336-343 (1998).
21. Hallstrom, M., Eerola, E., Janas, M. & Tammela, O. Effects of mode of delivery and necrotizing enterocolitis on the intestinal microflora in preterm infants. Eur. J. Clin. Microbiol. Infect. Dis. 23, 463-470 (2004).
22. Dai, D. & Walker, W. A. Protective nutrients and bacterial colonization in the immature human gut. Adv. Pediatr. 46, 353-382 (1999).
23. Fanaro, S., Chierici, R., Guerrini, P & Vigi, V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl. 91, 48-55 (2003).
24. Lederberg, J. & McCray, A. T. 'Ome sweet 'Omics - a genealogical treasury of words. Scientist 15, 8 (2001).
25. Illing, H. P. A. Techniques for microfloral and associated metabolic studies in relation to the absorption and enterohepatic circulation of drugs. Xenobiotica 11, 815-830 (1981).
26. Boxenbaum, H. G., Bekersky, I., Jack, M. J. & Kaplan, S. A. Influence of gut microflora on bioavailability. Drug. Met. Rev. 9, 259-279 (1979).
27. Nicholson, J. K. & Wilson, I. D. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nature Rev. Drug Discov. 2, 668-676 (2003).
28. Gilmore, M. S. & Ferretti, J. J. The thin line between gut commensal and pathogen. Science 299, 1999-2002 (2003).
29. Hooper, L. V. & Gordon, J. L. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118 (2001).
30. Yoshida, K. et al. Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. Chem. Res. Toxicol. 16, 1124-1129 (2003).
31. Adlerberth, I. et al. Intestinal colonization of Enterobacteriaceae in Pakistani and Swedish hospital-delivered children. Acta Pediatr. Scand. 80, 602-610 (1991).
32. Drasar, B. S., Montgomery, F. & Tomkins, A. M. Diet and faecal flora in three dietary groups in rural northern Nigeria. J. Hyg. 96, 59-65 (1986).
33. Mathan, V. I., Wiederman, J., Dobkin, J. F. & Lindenbaum, J. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 30, 971-977 (1989).
34. Kelly, D. et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear cytoplasmic shuttling of PPAR-γ and RelA. Nature Immunol. 5, 104-112 (2004).
35. Koo, S. H. et al. PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nature Med. 10, 530-534 (2004).
36. Wellen, K. E. & Hotamisligil, G. S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788 (2003).
37. Fekete, S. Recent findings and future perspectives of digestive physiology in rabbits: a review. Acta Vet. Hung. 37, 265-279 (1989).
38. Weimer, P. J. Manipulating ruminal fermentation: a microbial ecological perspective. J. Anim. Sci. 76, 3114-3122 (1998).
39. Rowland, I. R. Factors affecting metabolic activity of the intestinal microflora. Drug Met. Rev. 19, 243-261 (1988).
40. Caldwell, J. & Hawksworth, G. M. The demethylation of methamphetamine by intestinal microflora. J. Pharm. Pharmacol. 25, 422-4244 (1973).
41. Woolley, J. L. Jr & Siegel, C. W. The role of dietary nitrate and nitrite in the reductive deamination of sulfadiazine by the rat, guinea pig and neonatal calf. Life Sci. 30, 2229-2234 (1982).
42. Gardana, C., Simonetti, P., Canzi, E., Zanchi, R. & Pietta, P. Metabolism of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. J. Agric. Food. Chem. 51, 6618-6622 (2003).
43. Chourasia, M. K. & Jain, S. K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6, 33-66 (2003).
44. Bakke, J. E. & Gustafsson, J. A. Role of intestinal flora in metabolism of agrochemicals conjugated with glutathione. Xenobiotica 16, 1047-1056 (1986).
45. Buhler, R. et al. Human alcohol dehydrogenase: structural differences between the β and γ subunits suggest parallel duplications in isoenzyme evolution and predominant expression of separate gene descendants in livers of different mammals. Proc. Natl Acad. Sci. USA 81, 6320-6324 (1984).
46. Wostmann, B. S. The germ free animal in nutritional studies. Ann. Rev. Nutr. 1, 257-279 (1981).
47. Ogawa, H. et al. Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition. FEBS Lett. 554, 88-94 (2003).
48. Gordon, J. I., Hooper, L. V., McNevin, M. S., Wong, M. & Bry, L. Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium and diffuse GALT. Am. J. Physiol. 273, G565-G570 (1997).
49. Rawls, J. F., Samuel, B. S. & Gordon, J. I. Gnotobiotic zebrafish reveal evolutionary conserved responses to the gut microbiota. Proc. Natl Acad. Sci. USA 101, 4596-4601 (2004)
50. Tabita, K., Sakaguchi, S., Kozaki, S. & Sakaguchi, G. Comparative studies on Clostridium botulinum type A strains associated with infant botulism in Japan and in California, USA. Jpn. J. Med. Sci. Biol. 43, 219-231 (1990).
51. Danielson, P. B. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab. 3, 561-597 (2002).
52. Phipps, A. N., Stewart, J., Wright, B. & Wilson, I. D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28, 527-537 (1998).
53. 1H-nuclear magnetic resonance spectroscopy study. Xenobiotica 32, 783-794 (2002).
54. Park, B. K., Kitteringham, N. R., Powell, H. & Pirmohamed, M. Advances in molecular toxicology - towards understanding idiosyncratic drug toxicity. Toxicology 153, 39-60 (2000).
55. Ingelman-Sundberg, M. Polymorphism of cytochrome P450 and xenobiotic toxicity. Toxicology 181, 447-452 (2002).
56. Lindon, J. C et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137-146 (2003).
57. Ebbels, T. M. D. et al. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta 490, 109-122 (2003).
58. Akao T, et al. Baicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 52, 1563-1568 (2000).
59. Bowey, E., Adlercreutz, H. & Rowland, I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 41, 631-636 (2003).
60. Turner, N. J., Thomson, B. M. & Shaw, I. C. Bioactive isoflavones in functional foods: the importance of gut microflora and bioavailability. Nutr. Rev. 61, 204-213 (2003).
61. Gonthier, M. P. et al. Microbial aromatic metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 133, 461-467 (2003).
62. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal. Biochem. 323, 197-204 (2003).
63. Solanky, K. S. et al. NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat. J. Agric. Food Chem. 51, 4139-4145 (2003).
64. Beale, B. Probiotics: their tiny worlds are under scrutiny. Scientist 16, 20-22 (2002).
65. Wang, Y. et al. NMR-based metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 53, 191-196 (2005).
66. Peppercorn, M. A. & Goldman, P. Caffeic acid metabolism by bacteria of the human gastrointestinal tract. J. Bacteriol. 108, 996-1000 (1971).
67. Sullivan, A., Edlund, C. & Nord, C. E. Effect of antimicrobial agents on the ecological balance of human microflora. Scand. J. Infect. Dis. 33, 899-903 (2001).
68. Lode, H., Von der Hoh, N., Ziege, S., Borner, K. & Nord, C. E. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. J. Antimicrobiol. Chemother. 46, 741-749 (2000).
69. 1H NMR-based metabonomics. Nature Med. 8, 1439-1444 (2002).
70. 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J. Neurol. Sci. 212, 21-30 (2003).
71. Wang, Y. et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl Acad. Sci. USA 101, 12676-12681 (2004).
72. Fiehn, O. et al. Metabolite profiling for plant functional genomics. Nature Biotech. 18, 1157-1161 (2000).
73. Hall, R. et al. Plant metabolomics: the missing link in functional genomics strategies. Plant Cell 14, 1437-1440 (2002).
74. Kell, D. B. Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol. 7, 296-307 (2004).
75. Jonsson, P. et al. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal. Chem. 76, 1738-1745 (2004).
76. Clish, C. B. et al. Integrative biological analysis of the APOE3-leiden transgenic mouse. OMICS 8, 3-13 (2004).
77. Pham-Tuan, H., Kaskavelis, L., Daykin, C. A. & Janssen, H. G. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789, 283-301 (2003).
78. Plumb, R. S. et al. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun. Mass Spectrom. 16, 1991-1996 (2002).
79. Buchholz, A., Hurlebaus, J., Wandrey, C. & Takors, R. Metabolomics: quantification of intracellular metabolite dynamics. Biomol. Eng. 19, 5-15 (2002).
80. Nicholson, J. K. et al. High-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry (HPLC-ICP-MS) and orthogonal acceleration time-of-flight mass spectrometry (o/a-TOF-MS) for the simultaneous analysis and identification of the metabolites of 2-bromo-4-trifluoromethylacetaniline in rat urine. Anal. Chem. 73, 1491-1494 (2001).
81. Plumb, R. et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18, 2331-2337 (2004).
82. 1H NMR datasets. Anal. Chem. 77, 1282-1289 (2005).
83. Goodacre, R. et al. Rapid identification using pyrolysis mass spectrometry and artificial neural networks of Propionibacterium acnes isolated from dogs. J. Appl. Bacteriol. 76, 124-134 (1994).
84. Davey, H. M., Jones, A., Shaw, A. D. & Kell, D. B. Variable selection and multivariate methods for the identification of microorganisms by flow cytometry. Cytometry 35, 162-168 (1999).
85. Bolte, E. R. Autism and Clostridium tetani. Med. Hypotheses 51, 133-144 (1998).
86. Shaw, W. in Biological treatments for autism and PDD. 2nd edn 25-26 (The Great Plains Publishing Company, Winfield, Kansas, 2002).
87. Martirosian, G. Anaerobic intestinal microflora in pathogenesis of autism. Postepy. Hig. Med. Dosw. 58, 349-351 (2004).